A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial

Peer Review reports

Original Submission
31 Mar 2021	Submitted	Original manuscript
6 Apr 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
7 Apr 2021	Editorially accepted
19 Apr 2021	Article published	10.1186/s13063-021-05254-0

Back to article page